Page last updated: 2024-10-24

chloroquine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

chloroquine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 9 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's2 (22.22)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
He, W1
Zhao, CF1
Chen, L1
Hu, HX1
Chiou, JT1
Lee, YC1
Chang, LS1
Hseu, YC1
Shen, YC1
Kao, MC1
Mathew, DC1
Karuppaiya, P1
Li, ML1
Yang, HL1
Kamitsuji, Y1
Kuroda, J1
Kimura, S1
Toyokuni, S1
Watanabe, K1
Ashihara, E1
Tanaka, H1
Yui, Y1
Watanabe, M1
Matsubara, H1
Mizushima, Y1
Hiraumi, Y1
Kawata, E1
Yoshikawa, T1
Maekawa, T1
Nakahata, T1
Adachi, S1
Bellodi, C1
Lidonnici, MR1
Hamilton, A1
Helgason, GV1
Soliera, AR1
Ronchetti, M1
Galavotti, S1
Young, KW1
Selmi, T1
Yacobi, R1
Van Etten, RA1
Donato, N1
Hunter, A1
Dinsdale, D1
TirrĂ², E1
Vigneri, P1
Nicotera, P1
Dyer, MJ1
Holyoake, T1
Salomoni, P2
Calabretta, B2
Patel, H1
Marley, SB1
Gordon, MY1
Carew, JS1
Nawrocki, ST1
Kahue, CN1
Zhang, H1
Yang, C1
Chung, L1
Houghton, JA1
Huang, P1
Giles, FJ1
Cleveland, JL1
Jiang, YZ1
Mavroudis, D1
Dermime, S1
Hensel, N1
Couriel, D1
Molldrem, J1
Barrett, AJ1

Reviews

1 review available for chloroquine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Suppression of autophagy by BCR/ABL.
    Frontiers in bioscience (Scholar edition), 2012, 01-01, Volume: 4, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Benzamides; Chloroquine; Drug Sy

2012

Other Studies

8 other studies available for chloroquine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
[Chloroquine Enhances BIIB021-induced Apoptosis in Chronic Myeloid Leukemia Cells Bearing T315I Mutation].
    Zhongguo shi yan xue ye xue za zhi, 2022, Volume: 30, Issue:4

    Topics: Adenine; Animals; Apoptosis; Autophagy; Caspase 3; Cell Line, Tumor; Chloroquine; Fusion Proteins, b

2022
Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.
    Biochemical pharmacology, 2023, Volume: 218

    Topics: Apoptosis; Chloroquine; Glycolysis; Humans; Hydroquinones; K562 Cells; Leukemia, Myelogenous, Chroni

2023
Ganoderma tsugae induced ROS-independent apoptosis and cytoprotective autophagy in human chronic myeloid leukemia cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2019, Volume: 124

    Topics: Adenine; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Cell Sur

2019
The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias.
    Cell death and differentiation, 2008, Volume: 15, Issue:11

    Topics: Animals; Apoptosomes; Autophagy; Caspases; Cell Line, Tumor; Chloroquine; Cytoprotection; Disease Mo

2008
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.
    The Journal of clinical investigation, 2009, Volume: 119, Issue:5

    Topics: Animals; Antineoplastic Agents; Autophagy; Benzamides; Calcium; Cell Death; Cell Line, Tumor; Chloro

2009
Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2.
    Genes, chromosomes & cancer, 2006, Volume: 45, Issue:12

    Topics: Adaptor Proteins, Signal Transducing; Caspases; Cell Line, Tumor; Chloroquine; Fusion Proteins, bcr-

2006
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance.
    Blood, 2007, Jul-01, Volume: 110, Issue:1

    Topics: Antineoplastic Agents; Autophagy; Cathepsin D; Cell Line, Tumor; Chloroquine; Drug Resistance, Neopl

2007
Alloreactive CD4+ T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen.
    British journal of haematology, 1996, Volume: 93, Issue:3

    Topics: Bone Marrow Transplantation; Brefeldin A; CD4-Positive T-Lymphocytes; Chloroquine; Cyclopentanes; Cy

1996